Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma

This study has been completed.
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00019383
First received: July 11, 2001
Last updated: February 6, 2009
Last verified: June 2003
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given